ImmunoPrecise Antibodies Ltd. Quarterly Liabilities in CAD from Q1 2020 to Q3 2024

Taxonomy & unit: ifrs-full: CAD
Summary: ImmunoPrecise Antibodies Ltd. quarterly Liabilities history and growth rate from Q1 2020 to Q3 2024.
ImmunoPrecise Antibodies Ltd. Liabilities for the quarter ending October 31, 2024 was CA$27.3M, a 15.7% increase year-over-year.

Liabilities, Quarterly (CAD)

Liabilities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	27.3M	+3.71M	+15.7%	Oct 31, 2024	6-K	2024-12-10
Q2 2024	26.4M			Jul 31, 2024	6-K	2024-09-16
Q1 2024	24.3M	+4.3M	+21.5%	Apr 30, 2024	6-K	2024-12-10
Q4 2023	28.9M			Jan 31, 2024	6-K	2024-03-14
Q3 2023	23.6M			Oct 31, 2023	6-K/A	2024-02-15
Q1 2023	20M	+1.65M	+8.98%	Apr 30, 2023	20-F	2024-07-29
Q1 2022	18.4M	+8.33M	+83%	Apr 30, 2022	40-F	2023-07-10
Q1 2021	10M	-2.14M	-17.6%	Apr 30, 2021	40-F	2022-07-29
Q1 2020	12.2M			Apr 30, 2020	40-F/A	2021-09-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.